Understanding Advanced Prostate Cancer

Comparing (18)F-FACBC (anti1-amino-3-(18)F-fluorocyclobutane-1-carboxylic acid) and (11)C-choline PET/CT in Prostate Cancer Relapse

There has been a lot of hype and confusion about what is the best contrast for prostate cancer PET/CT scans. The two newest contrasts; (18)F-FACBC (anti1-amino-3-(18)F-fluorocyclobutane-1-carboxylic acid) and (11)C-choline both have their supporters and their detractors. To try and evaluate the efficacy differences between these two contrasts in men who have suffered a bio-chemical recurrence [...]

By Malecare|2016-03-22T12:09:28-04:00March 22nd, 2016|(18)F-FACBC, [11C] choline PET/CT, Advanced Prostate Cancer, Bio Chemical Recurrence, General Information, Imaging, Scanning Technology, Technology, Uncategorized, Understanding Advanced Prostate Cancer|0 Comments

PSA Decline After 4 Weeks of Abiraterone Suggests Overall Survival in Men with Metastatic Castration-Resistant Prostate Cancer

Since we have many new treatments for men with castrate resistant metastatic prostate cancer (mCRPC) (advanced prostate cancer) we need to develop earlier indicators of when a treatment might or might not be successful. A decline in prostate-specific antigen (PSA) is widely used to monitor treatment response, but it has not been validated as an [...]

By Malecare|2016-03-15T23:25:25-04:00March 15th, 2016|abiraterone acetate, Advanced Prostate Cancer, biomarkers, Clinical Trials & Research, Drugs & Treatments, PSA, Survival, survival, Uncategorized, Understanding Advanced Prostate Cancer, United Kingdom - England, Northern Ireland, Scotland & Wales, Zytiga|1 Comment

The Benefit of Using Local Prostate Cancer Therapy for Men with Lymph Node Positive Disease

In an issue of ONCOLOGY, there was a review of the literature provides us with a comprehensive review of the limited literature on management of men with prostate cancer who have pelvic lymph node involvement but no known distant metastatic disease at diagnosis. Common folklore has been that these men, with limited pelvic lymph node [...]

By Malecare|2021-02-17T10:41:00-05:00February 23rd, 2016|adjuvant therapy, Advanced Prostate Cancer, Drugs & Treatments, Radiotherapy, Surgery, Survival, Uncategorized, Understanding Advanced Prostate Cancer|0 Comments

PET/CT Scans More Sensitive Than CT and Bone Scans For Detecting Metastatic Prostate Cancer

According to an article in the Journal of Nuclear Medicine, researchers compared a PET/CT scan using the radiotracer F-18 DCFBC to conventional imaging modalities — an expanded Tc-99m-methylene diphosphonate (MDP) bone scan and contrast-enhanced CT of the chest, abdomen and pelvis — to detect prostate-specific membrane antigen (PSMA), which is associated with prostate cancer metastases. [...]

By Malecare|2017-10-19T10:46:39-04:00February 5th, 2016|Advanced Prostate Cancer, CTCs, F-18 DCFBC, General Information, Imaging, Technology, Uncategorized, Understanding Advanced Prostate Cancer|0 Comments

Can Radiotherapy (Radiation) for the Primary Tumors Benefit Men With Prostate CancerWith Distant Metastasis at Initial Diagnosis?

The common belief is that if you are diagnosed with prostate cancer that has already developed metastases only a systemic treatment will provide a life extending benefit. In other cancers it has been shown that the treatment of the primary tumor improves survival (tumor debulking). To find out if, in fact radiotherapy treatment of the [...]

By Malecare|2016-01-28T11:22:12-05:00January 28th, 2016|Advanced Prostate Cancer, Bio Chemical Recurrence, Bone Metastases, Drugs & Treatments, General Information, Radiotherapy, survival, Uncategorized, Understanding Advanced Prostate Cancer|0 Comments